• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

AHA/ACC 2018 Guidelines on Treatment of Blood Cholesterol: Quiz #1

News
Slideshow

What's new and what's not in the AHA/ACC 2018 update to the 2013 lipid management guidelines? Try part I of our 3-part quiz and find out.

Take this first in a series of 3 short quizzes to test your knowledge of what’s different in the 2018 vs 2013 AHA/ACC guidelines and what may be the same.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor

Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor

Patient Care Staff
January 17th 2025
Article

Mineralys Therapeutics also expects topline data from its phase 2 study of lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension when used as an add-on therapy.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Mobile App Shows Promise for Hypertension Management: Daily Dose / image credit: ©New Africa/AdobeStock

Mobile App Shows Promise for Hypertension Management: Daily Dose

Sydney Jennings
January 9th 2025
Article

Your daily dose of the clinical news you may have missed.

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Patient Care Editorial Staff
October 29th 2020
Podcast

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

More than Half of US Adults Eligible for Semaglutide: Daily Dose / image credit: ©New Africa/AdobeStock

More than Half of US Adults Eligible for Semaglutide: Daily Dose

Sydney Jennings
December 9th 2024
Article

Your daily dose of the clinical news you may have missed.

Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose

Sydney Jennings
December 4th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.